发明名称 Dosage forms having prolonged active ingredient release
摘要 <p>A pharmaceutical unit dosage form comprising a therapeuically effective dose of a 4-phenylbutyric acid salt having prolonged release of the active ingredient, being suitable for alleviating and curing various diseases upon once or twice daily oral administration, a method of preparation of said pharmaceutical formulation and the use thereof for the treatment of benign prostate hyperplasy, cancer, leukemias, cystic fibrosis, AàIDS, kidney and liver diseases, thalassemia and urea cycle disorders comprising the twice-daily oral administration of a therapeutically effective dosage thereof to a patient.</p>
申请公布号 EP1291015(A1) 申请公布日期 2003.03.12
申请号 EP20010810865 申请日期 2001.09.10
申请人 LUNAMED AG 发明人 TRUOG, PETER
分类号 A61K9/20;A61K9/22;A61K9/28;A61K9/32;A61K31/192;A61K47/04;A61K47/12;A61K47/14;A61K47/26;A61K47/32;A61K47/34;A61K47/38;A61K47/44;A61P1/16;A61P1/18;A61P3/12;A61P7/06;A61P11/00;A61P13/02;A61P13/08;A61P13/12;A61P31/18;A61P35/00;A61P35/02;A61P37/04;(IPC1-7):A61K9/22 主分类号 A61K9/20
代理机构 代理人
主权项
地址